New web portal, built in collaboration with GlobalCures, will accelerate the open medical research approach to discover affordable, effective repurposed therapies

Cures Within Reach, in preparation for its 2nd Annual BioScience Awards Midwest (BAM), is pleased to name its researcher award, in perpetuity, after the recently deceased Dr. Janet Davison Rowley (1925-2013), of the University of Chicago.

Medical research nonprofit Cures Within Reach will present three awards recognizing personal efforts to improve patient lives through science, business and philanthropy at the 2nd Annual Bioscience Awards Midwest (BAM) event on June 17 in Chicago.

Organizers for the 2nd Annual Bioscience Awards of the Midwest (BAM event) from Cures Within Reach have announced corporate sponsors for the event, which is slated for June 17, 2014, at the Standard Club in Chicago.

Medical research nonprofit Cures Within Reach has confirmed the co-chair committee for the 2nd Annual BioScience Awards of the Midwest (BAM) scheduled for June 17, 2014, at the Standard Club in Chicago.

Cures Within Reach is pleased to name Illinois Governor Pat Quinn as honorary chair of the 2nd Bioscience Awards Midwest event on June 17, 2014, celebrating patient impact through science, philanthropy and business.

Cures Within Reach (Cures), a non-profit dedicated to medical repurposing research, will be represented by Dr. Bruce Bloom and Dr. E. Mitchell Seymour on the Editorial Board of a new journal entitled “Drug Repurposing, Rescue, and Repositioning."

In recognition of the 7th Annual Rare Disease Day on February 28, two Chicago-area nonprofit organizations are joining forces by repurposing music and medicine to raise awareness of rare diseases through a grassroots campaign to help children.

Cures Within Reach is pleased to announce that Dr. Norbert G. Riedel will receive its Patient Impact Legacy Award at its Midwest BioScience Industry Gala on the evening of June 17th, 2014, in downtown Chicago.

Cures Within Reach is partnering with BioMotiv to drive repurposing research toward patient impact, with initial focus on therapies for Lung Cancer.